Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SARAH JEANE SMITH

Allopathic & Osteopathic Physicians Family Medicine

NPI
1780857649
CMS profile
840889
Location
SHEBOYGAN, WI

General Payments · PY2019–2024

$66,363.70

  • Reported across 52 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$31,979.91

23 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $31,671.84 18
Travel and Lodging $308.07 5

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Takeda Pharmaceuticals U.S.A., Inc. $31,979.91 23

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $20.08 1
PY2020 $11.28 1
PY2021 $28.29 2
PY2022 $12,377.42 9
PY2023 $21,946.72 16
PY2024 $31,979.91 23

Payment records · PY2024 (23)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Takeda Pharmaceuticals U.S.A., Inc. $1,993.34 01/17/2024 Consulting Fee Undisputed 01/23/2026 1137678791 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,993.34 02/14/2024 Consulting Fee Undisputed 01/23/2026 1137678793 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,993.34 03/11/2024 Consulting Fee Undisputed 01/23/2026 1137678795 CMS
Takeda Pharmaceuticals U.S.A., Inc. $996.68 04/08/2024 Consulting Fee Undisputed 01/23/2026 1137678797 CMS
Takeda Pharmaceuticals U.S.A., Inc. $43.15 04/08/2024 Travel and Lodging Undisputed 01/23/2026 1137678799 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,993.34 04/17/2024 Consulting Fee Undisputed 01/23/2026 1137678801 CMS
Takeda Pharmaceuticals U.S.A., Inc. $996.68 04/22/2024 Consulting Fee Undisputed 01/23/2026 1137678803 CMS
Takeda Pharmaceuticals U.S.A., Inc. $43.15 04/22/2024 Travel and Lodging Undisputed 01/23/2026 1137678805 CMS
Takeda Pharmaceuticals U.S.A., Inc. $996.68 05/06/2024 Consulting Fee Undisputed 01/23/2026 1137678807 CMS
Takeda Pharmaceuticals U.S.A., Inc. $65.66 05/06/2024 Travel and Lodging Undisputed 01/23/2026 1137678809 CMS
Takeda Pharmaceuticals U.S.A., Inc. $996.68 05/10/2024 Consulting Fee Undisputed 01/23/2026 1137678811 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,993.34 05/10/2024 Consulting Fee Undisputed 01/23/2026 1137678813 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,093.34 06/10/2024 Consulting Fee Undisputed 01/23/2026 1137678815 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,495.02 07/03/2024 Consulting Fee Undisputed 01/23/2026 1137678817 CMS
Takeda Pharmaceuticals U.S.A., Inc. $98.49 07/03/2024 Travel and Lodging Undisputed 01/23/2026 1137678819 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,570.02 07/03/2024 Consulting Fee Undisputed 01/23/2026 1137678821 CMS
Takeda Pharmaceuticals U.S.A., Inc. $57.62 07/03/2024 Travel and Lodging Undisputed 01/23/2026 1137678823 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,093.34 07/12/2024 Consulting Fee Undisputed 01/23/2026 1137678825 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,093.34 08/09/2024 Consulting Fee Undisputed 01/23/2026 1137678827 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,093.34 09/11/2024 Consulting Fee Undisputed 01/23/2026 1137678829 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,093.34 10/09/2024 Consulting Fee Undisputed 01/23/2026 1137678831 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,093.34 11/13/2024 Consulting Fee Undisputed 01/23/2026 1137678833 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,093.34 12/09/2024 Consulting Fee Undisputed 01/23/2026 1137678835 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.